480 related articles for article (PubMed ID: 21862781)
1. Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction.
Thornton RH; Frank BS; Covey AM; Maybody M; Solomon SB; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2011 Sep; 197(3):W514-8. PubMed ID: 21862781
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction.
Shim DJ; Gwon DI; Han K; Kim Y; Ko GY; Shin JH; Ko HK; Kim JH; Kim JW; Yoon HK; Sung KB
Korean J Radiol; 2018; 19(4):597-605. PubMed ID: 29962866
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not?
Inal M; Aksungur E; Akgül E; Oguz M; Seydaoglu G
Cardiovasc Intervent Radiol; 2003; 26(1):40-5. PubMed ID: 12491022
[TBL] [Abstract][Full Text] [Related]
4. Malignant biliary obstruction: treatment with interventional radiology.
Zhai R; Qian X; Dai D; Yu P
Chin Med J (Engl); 2003 Jun; 116(6):888-92. PubMed ID: 12877801
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous biliary covered stent insertion in patients with malignant duodenobiliary obstruction.
Lee E; Gwon DI; Ko GY; Sung KB; Yoon HK; Shin JH; Kim JH; Ko HK; Song HY
Acta Radiol; 2015 Feb; 56(2):166-73. PubMed ID: 24518689
[TBL] [Abstract][Full Text] [Related]
6. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
Freeman ML; Overby C
Gastrointest Endosc; 2003 Jul; 58(1):41-9. PubMed ID: 12838219
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes after percutaneous biliary interventions in patients with malignant biliary obstruction caused by metastatic gastric cancer.
Gwon DI; Ko GY; Sung KB; Yoon HK; Kim KA; Kim YJ; Kim TH; Lee WH
Acta Radiol; 2012 May; 53(4):422-9. PubMed ID: 22403081
[TBL] [Abstract][Full Text] [Related]
8. Malignant biliary disease: percutaneous interventions.
Morgan RA; Adam AN
Tech Vasc Interv Radiol; 2001 Sep; 4(3):147-52. PubMed ID: 11748553
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous stent-in-stent placement with large cell-type stents for malignant hilar biliary obstruction.
Kim GH; Gwon DI; Ko GY; Kim JH; Kim JW; Chu HH; Yoon HK; Sung KB
Acta Radiol; 2021 Dec; 62(12):1625-1631. PubMed ID: 33307712
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous bilateral metallic stent placement using a stentin-stent deployment technique in patients with malignant hilar biliary obstruction.
Gwon DI; Ko GY; Kim JH; Shin JH; Kim KA; Yoon HK; Sung KB
AJR Am J Roentgenol; 2013 Apr; 200(4):909-14. PubMed ID: 23521469
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous transhepatic hybrid biliary endoprostheses using both plastic and metallic stents for palliative treatment of malignant common bile duct obstruction.
Fujita T; Tanabe M; Takahashi S; Iida E; Matsunaga N
Eur J Cancer Care (Engl); 2013 Nov; 22(6):782-8. PubMed ID: 23834370
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous transcholecystic metallic stent placement for malignant obstruction of the common bile duct: preliminary clinical evaluation.
Yasumoto T; Yokoyama S; Nagaike K
J Vasc Interv Radiol; 2010 Feb; 21(2):252-8. PubMed ID: 20123209
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of percutaneous Y-configured covered stent placement for malignant hilar biliary obstruction: a prospective, pilot study.
Gwon DI; Ko GY; Yoon HK; Kim YJ; Kim TH; Lee WH; Sung KB
J Vasc Interv Radiol; 2012 Apr; 23(4):528-34. PubMed ID: 22341884
[TBL] [Abstract][Full Text] [Related]
14. Combined T/Y biliary stent placement for the treatment of biliary obstruction caused by Bismuth-Corlett type IV hilar cholangiocarcinoma.
Li TF; Li Z; Han XW; Ren JZ; Jiao C; Bi YH; Ren KW
Hepatogastroenterology; 2014 Sep; 61(134):1519-22. PubMed ID: 25436335
[TBL] [Abstract][Full Text] [Related]
15. Fractures of self-expanding metallic stents in periampullary malignant biliary obstruction.
Rasmussen IC; Dahlstrand U; Sandblom G; Eriksson LG; Nyman R
Acta Radiol; 2009 Sep; 50(7):730-7. PubMed ID: 19551534
[TBL] [Abstract][Full Text] [Related]
16. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of percutaneous transhepatic endobiliary radiofrequency ablation as an adjunct to biliary stenting in malignant biliary obstruction.
Acu B; Kurtulus Ozturk E
Diagn Interv Imaging; 2018 Apr; 99(4):237-245. PubMed ID: 29102756
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine.
Dambrauskas Z; Paskauskas S; Lizdenis P; Uktveris R; Pranculis A; Kaupas RS; Barauskas G; Pundzius J
Medicina (Kaunas); 2008; 44(12):969-76. PubMed ID: 19142055
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of refractory malignant biliary obstraction: comparing results of percutaneous transhepatic biliary drainage with external catheters or endoscopic metallic stenting].
Zou XP; Zhan XB; Li ZS; Jin ZD; Wan XJ; Wang N; Xu GM
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):109-11. PubMed ID: 15059407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
